Pepito Veincent Christian F, Loreche Arianna Maever, Samontina Rae Erica D, Abdon Sarah Jane A, Fuentes David Norman L, Saniel Ofelia P
College of Public Health, University of the Philippines Manila, Manila, Philippines.
School of Medicine and Public Health, Ateneo de Manila University, Pasig City, Philippines.
Heliyon. 2023 Jul 6;9(7):e17975. doi: 10.1016/j.heliyon.2023.e17975. eCollection 2023 Jul.
Treatment adherence is a vital aspect in the management of chronic diseases like leprosy; however, most studies on treatment adherence focus on patients. This study aims to examine the perceptions of healthcare providers on factors that can promote or prevent patients from adhering to treatment.
We conducted three focus group discussions (FGDs) with healthcare providers who have at least one year experience in managing leprosy in three large leprosy case-holding hospitals in Metro Manila, Philippines. We audio-recorded, transcribed, translated the FGD proceedings, and analyzed the transcripts thematically to identify patient-intrinsic and patient-extrinsic enablers and barriers to treatment adherence of leprosy patients.
Patient-intrinsic motivators to complete treatment include innate desire to be cured, fear of infecting family and friends, fear of disability, good knowledge about the disease, need for medical clearance to be considered fit to work, and experiencing leprosy reactions. Patient-extrinsic motivators to complete treatment include free treatment, immediate and sufficient counselling, flexibility in treatment, follow-up and motivation of healthcare workers, and presence of Hansen's Club and support groups. Patient-intrinsic barriers to good treatment adherence include distance between residence and hospital, financial and opportunity costs, adverse drug reactions, misconceptions about being cured, disabilities and presence of leprosy reactions, stubbornness and/or laziness, and undergoing clinical depression. Patient-extrinsic barriers to good treatment adherence include poor availability of MDT, transfer to other leprosy treatment facilities without informing current facility, and stigma.
Healthcare providers perceive that patient-intrinsic and patient-extrinsic factors influence the treatment adherence of leprosy patients through different mechanisms. We highlight the role of healthcare provider attitudes, stigma, and support groups in promoting treatment adherence.
治疗依从性是麻风病等慢性病管理中的一个重要方面;然而,大多数关于治疗依从性的研究都集中在患者身上。本研究旨在探讨医疗服务提供者对可促进或阻碍患者坚持治疗的因素的看法。
我们在菲律宾马尼拉大都会的三家大型麻风病收治医院,与至少有一年麻风病管理经验的医疗服务提供者进行了三次焦点小组讨论(FGD)。我们对FGD过程进行了录音、转录、翻译,并对转录本进行了主题分析,以确定麻风病患者坚持治疗的患者内在和患者外在的促进因素和障碍。
完成治疗的患者内在动机包括治愈的内在愿望、害怕感染家人和朋友、害怕残疾、对疾病的充分了解、需要医疗证明以被认为适合工作以及经历麻风反应。完成治疗的患者外在动机包括免费治疗、即时且充分的咨询、治疗的灵活性、医护人员的随访和激励,以及汉森俱乐部和支持小组的存在。良好治疗依从性的患者内在障碍包括住所与医院之间的距离、经济和机会成本、药物不良反应、对治愈的误解、残疾和麻风反应的存在、固执和/或懒惰,以及患有临床抑郁症。良好治疗依从性的患者外在障碍包括多药联合疗法(MDT)供应不足、未通知当前医疗机构就转至其他麻风病治疗机构,以及耻辱感。
医疗服务提供者认为,患者内在和患者外在因素通过不同机制影响麻风病患者的治疗依从性。我们强调了医疗服务提供者态度、耻辱感和支持小组在促进治疗依从性方面的作用。